172 research outputs found
The pre-launch Planck Sky Model: a model of sky emission at submillimetre to centimetre wavelengths
We present the Planck Sky Model (PSM), a parametric model for the generation
of all-sky, few arcminute resolution maps of sky emission at submillimetre to
centimetre wavelengths, in both intensity and polarisation. Several options are
implemented to model the cosmic microwave background, Galactic diffuse emission
(synchrotron, free-free, thermal and spinning dust, CO lines), Galactic H-II
regions, extragalactic radio sources, dusty galaxies, and thermal and kinetic
Sunyaev-Zeldovich signals from clusters of galaxies. Each component is
simulated by means of educated interpolations/extrapolations of data sets
available at the time of the launch of the Planck mission, complemented by
state-of-the-art models of the emission. Distinctive features of the
simulations are: spatially varying spectral properties of synchrotron and dust;
different spectral parameters for each point source; modeling of the clustering
properties of extragalactic sources and of the power spectrum of fluctuations
in the cosmic infrared background. The PSM enables the production of random
realizations of the sky emission, constrained to match observational data
within their uncertainties, and is implemented in a software package that is
regularly updated with incoming information from observations. The model is
expected to serve as a useful tool for optimizing planned microwave and
sub-millimetre surveys and to test data processing and analysis pipelines. It
is, in particular, used for the development and validation of data analysis
pipelines within the planck collaboration. A version of the software that can
be used for simulating the observations for a variety of experiments is made
available on a dedicated website.Comment: 35 pages, 31 figure
Recommended from our members
Impact of particles on the Planck HFI detectors: Ground-based measurements and physical interpretation
The Planck High Frequency Instrument (HFI) surveyed the sky continuously from
August 2009 to January 2012. Its noise and sensitivity performance were
excellent, but the rate of cosmic ray impacts on the HFI detectors was
unexpectedly high. Furthermore, collisions of cosmic rays with the focal plane
produced transient signals in the data (glitches) with a wide range of
characteristics. A study of cosmic ray impacts on the HFI detector modules has
been undertaken to categorize and characterize the glitches, to correct the HFI
time-ordered data, and understand the residual effects on Planck maps and data
products. This paper presents an evaluation of the physical origins of glitches
observed by the HFI detectors. In order to better understand the glitches
observed by HFI in flight, several ground-based experiments were conducted with
flight-spare HFI bolometer modules. The experiments were conducted between 2010
and 2013 with HFI test bolometers in different configurations using varying
particles and impact energies. The bolometer modules were exposed to 23 MeV
protons from the Orsay IPN TANDEM accelerator, and to Am and Cm
-particle and Fe radioactive X-ray sources. The calibration data
from the HFI ground-based preflight tests were used to further characterize the
glitches and compare glitch rates with statistical expectations under
laboratory conditions. Test results provide strong evidence that the dominant
family of glitches observed in flight are due to cosmic ray absorption by the
silicon die substrate on which the HFI detectors reside. Glitch energy is
propagated to the thermistor by ballistic phonons, while there is also a
thermal diffusion contribution. The implications of these results for future
satellite missions, especially those in the far-infrared to sub-millimetre and
millimetre regions of the electromagnetic spectrum, are discussed.Comment: 11 pages, 13 figure
Magnetic Fields in the Milky Way
This chapter presents a review of observational studies to determine the
magnetic field in the Milky Way, both in the disk and in the halo, focused on
recent developments and on magnetic fields in the diffuse interstellar medium.
I discuss some terminology which is confusingly or inconsistently used and try
to summarize current status of our knowledge on magnetic field configurations
and strengths in the Milky Way. Although many open questions still exist, more
and more conclusions can be drawn on the large-scale and small-scale components
of the Galactic magnetic field. The chapter is concluded with a brief outlook
to observational projects in the near future.Comment: 22 pages, 5 figures, to appear in "Magnetic Fields in Diffuse Media",
eds. E.M. de Gouveia Dal Pino and A. Lazaria
Small-molecule inhibitor of Bcl-2 (TW-37) suppresses growth and enhances cisplatin-induced apoptosis in ovarian cancer cells
Management of multi-language business processes with "AProMoRe"
International audienceAPROMORE (Advanced PROocess MOdel REpository) is an open and extensible plat- form meant to face the challenge of how to deal with an increasing number of business process models within or accross organisations
Management of multi-language business processes with "AProMoRe"
International audienceAPROMORE (Advanced PROocess MOdel REpository) is an open and extensible plat- form meant to face the challenge of how to deal with an increasing number of business process models within or accross organisations
Minicircle-oriP-IFNÎł: A Novel Targeted Gene Therapeutic System for EBV Positive Human Nasopharyngeal Carcinoma
) in which the transgene expression was under the transcriptional regulation of oriP promoter.. Immunohistochemistry was used to detect the expression and the activity of the IFNÎł in tumor sections. Our results demonstrated that mc-oriP vectors mediated comparable gene expression and anti-proliferative effect in the EBV-positive NPC cell line C666-1 compared to mc-CMV vectors. Furthermore, mc-oriP vectors exhibited much lower killing effects on EBV-negative cell lines compared to mc-CMV vectors. The targeted expression of mc-oriP vectors was inhibited by EBNA1-siRNA in C666-1. This selective expression was corroborated in EBV-positive and -negative tumor models. as a safe and highly effective targeted gene therapeutic system for the treatment of EBV positive NPC
The Role of Alpha-Synuclein Oligomerization and Aggregation in Cellular and Animal Models of Parkinson’s Disease
α-synuclein (α-syn) is a synaptic protein in which four mutations (A53T, A30P, E46K and gene triplication) have been found to cause an autosomal dominant form of Parkinson’s disease (PD). It is also the major component of intraneuronal protein aggregates, designated as Lewy bodies (LBs), a prominent pathological hallmark of PD. How α-syn contributes to LB formation and PD is still not well-understood. It has been proposed that aggregation of α-syn contributes to the formation of LBs, which then leads to neurodegeneration in PD. However, studies have also suggested that aggregates formation is a protective mechanism against more toxic α-syn oligomers. In this study, we have generated α-syn mutants that have increased propensity to form aggregates by attaching a CL1 peptide to the C-terminal of α-syn. Data from our cellular study suggest an inverse correlation between cell viability and the amount of α-syn aggregates formed in the cells. In addition, our animal model of PD indicates that attachment of CL1 to α-syn enhanced its toxicity to dopaminergic neurons in an age-dependent manner and induced the formation of Lewy body-like α-syn aggregates in the substantia nigra. These results provide new insights into how α-syn-induced toxicity is related to its aggregation
Antiprogestin mifepristone inhibits the growth of cancer cells of reproductive and non-reproductive origin regardless of progesterone receptor expression
<p>Abstract</p> <p>Background</p> <p>Mifepristone (MF) has been largely used in reproductive medicine due to its capacity to modulate the progesterone receptor (PR). The study of MF has been expanded to the field of oncology; yet it remains unclear whether the expression of PR is required for MF to act as an anti-cancer agent. Our laboratory has shown that MF is a potent inhibitor of ovarian cancer cell growth. In this study we questioned whether the growth inhibitory properties of MF observed in ovarian cancer cells would translate to other cancers of reproductive and non-reproductive origin and, importantly, whether its efficacy is related to the expression of cognate PR.</p> <p>Methods</p> <p>Dose-response experiments were conducted with cancer cell lines of the nervous system, breast, prostate, ovary, and bone. Cultures were exposed to vehicle or increasing concentrations of MF for 72 h and analysed for cell number and cell cycle traverse, and hypodiploid DNA content characteristic of apoptotic cell death. For all cell lines, expression of steroid hormone receptors upon treatment with vehicle or cytostatic doses of MF for 24 h was studied by Western blot, whereas the activity of the G1/S regulatory protein Cdk2 in both treatment groups was monitored <it>in vitro </it>by the capacity of Cdk2 to phosphorylate histone H1.</p> <p>Results</p> <p>MF growth inhibited all cancer cell lines regardless of tissue of origin and hormone responsiveness, and reduced the activity of Cdk2. Cancer cells in which MF induced G1 growth arrest were less susceptible to lethality in the presence of high concentrations of MF, when compared to cancer cells that did not accumulate in G1. While all cancer cell lines were growth inhibited by MF, only the breast cancer MCF-7 cells expressed cognate PR.</p> <p>Conclusions</p> <p>Antiprogestin MF inhibits the growth of different cancer cell lines with a cytostatic effect at lower concentrations in association with a decline in the activity of the cell cycle regulatory protein Cdk2, and apoptotic lethality at higher doses in association with increased hypodiploid DNA content. Contrary to common opinion, growth inhibition of cancer cells by antiprogestin MF is not dependent upon expression of classical, nuclear PR.</p
- …